Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.13M Hold
3,545,719
1.35% 8
2026
Q1
$7.62M Hold
3,545,719
2.18% 7
2025
Q4
$5.53M Hold
3,545,719
2% 6
2025
Q3
$10.5M Hold
3,545,719
4.6% 4
2025
Q2
$4.96M Hold
3,545,719
2.3% 5
2025
Q1
$4.36M Hold
3,545,719
2.65% 5
2024
Q4
$6.7M Buy
+3,545,719
New +$13.3M 2.6% 5

Other funds holding ALEC

Merck & Co's ALEC Position: Q2 2026 in Review

Merck & Co held its Alector (ALEC) position steady in Q2 2026 at 3,545,719 shares worth $7.13M. The position accounts for 1.35% of the portfolio, ranked #8.

Merck & Co first reported a position in ALEC in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.5M in Q3 2025. 140 funds tracked by Wall St. Rank hold ALEC as of Q2 2026.

  • Merck & Co held 3,545,719 shares of Alector worth $7.13M as of Q2 2026.
  • Merck & Co left its Alector share count unchanged in Q2 2026.
  • Alector made up 1.35% of Merck & Co's portfolio in Q2 2026, its #8 holding.
  • Merck & Co first reported a position in Alector in Q4 2024 and has held it in 7 quarters since.
  • Merck & Co's Alector position peaked at $10.5M in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Alector as of Q2 2026.

Based on Merck & Co's 13F filing for Q2 2026, filed 7 Aug 2026.